QSS
ASMB icon

Quantitative Systematic Strategies’s Assembly Biosciences ASMB Stock Holding History

Quantitative Systematic Strategies’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-843
Closed -$376K – 693
2018
Q3 		$376K Buy
843
+103
+14% +$48.2K 0.07% 363
2018
Q2 		$348K Buy
+740
New +$391K 0.06% 429

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Quantitative Systematic Strategies's ASMB Position: Q4 2018 in Review

Quantitative Systematic Strategies sold out of Assembly Biosciences (ASMB) in Q4 2018, closing a stake of 843 shares — an estimated $376K sold.

Quantitative Systematic Strategies first reported a position in ASMB in Q2 2018 and held it in 2 quarters. The position peaked at $376K in Q3 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q4 2018.

  • Quantitative Systematic Strategies reported no remaining Assembly Biosciences position as of Q4 2018 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 843 Assembly Biosciences shares in Q4 2018, an estimated $376K.
  • Quantitative Systematic Strategies first reported a position in Assembly Biosciences in Q2 2018 and held it in 2 quarters.
  • Quantitative Systematic Strategies's Assembly Biosciences position peaked at $376K in Q3 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2018.

Based on Quantitative Systematic Strategies's 13F filing for Q4 2018, filed 12 Feb 2019.